Analytical Data
-
基因名
MAFG
- Application
-
别名
MAFG;Transcription factor MafG
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O15525
-
表达区间
1-162aa
-
氨基酸序列
MTTPNKGNKA LKVKREPGEN GTSLTDEELV TMSVRELNQH LRGLSKEEIV QLKQRRRTLK NRGYAASCRV KRVTQKEELE KQKAELQQEV EKLASENASM KLELDALRSK YEALQTFART VARSPVAPAR GPLAAGLGPL VPGKVAATSV ITIVKSKTDA RS
-
分子量
20 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MAFG (Maf G proto-oncogene) is a member of the basic leucine zipper (bZIP) transcription factor family and has garnered interest due to its role in regulating various biological processes, including cell differentiation, apoptosis, and responses to oxidative stress. Research suggests that MAFG is involved in the transcriptional regulation of genes related to metabolic pathways and has been implicated in the pathogenesis of several diseases, notably cancer and cardiovascular conditions. The protein is understood to interact with other transcription factors and co-regulators, influencing gene expression in response to physiological and pathological stimuli. Recent studies have focused on the potential of MAFG as a biomarker for disease progression and as a therapeutic target, given its significant role in cellular responses to environmental changes. Understanding the structure and function of MAFG through the study of recombinant proteins could illuminate the molecular mechanisms of its action, paving the way for novel therapeutic strategies. Consequently, the recombinant expression and characterization of MAFG provide essential insights into its functional roles, interactions, and potential applications in medicine. Researchers are actively investigating the modular domains of MAFG, exploring how its reconstitution may benefit the development of small molecule inhibitors that could modulate its activity in disease contexts.
